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a b s t r a c t 
Chest pain is a common clinical condition in the emergency 
department. A high sensitive (hs) troponin test assay may 
help to identify patients with acute coronary syndrome ear- 
lier compared to conventional tests but also entails the risk 
of a high proportion of positive test results in patients with- 
out cardiac disease. We assessed the impact of the introduc- 
tion of the hs-troponin test in clinical practice in an emer- 
gency department. 
We compared December 1, 2009 until November 30, 2010 
(standard test period) to December 1, 2010 – the date of the 
introduction of the hs-troponin assay – until December 31, 
2011 (hs troponin test period) of patients presenting with 
chest pain to one of the ten largest hospitals in Switzerland. 
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We identified electronic health records using the follow- 
ing ICD-10 codes: R06.4 (hyperventilation), R07.1 (chest pain 
when breathing), R07.2 (precordial pain), R07.3 (other chest 
pain), and R07.4 (chest pain not specified), I20 (angina pec- 
toris), I21 (acute MI), I22 (recurrent MI), I23 (complications 
after acute MI), and I24 (other acute ischemic heart disease). 
Included were all medical records of adult patients ( ≥18 
years) presenting to the ED with chest pain and with 
≥1 troponin test. Excluded were records without tro- 
ponin test, pregnancy, trauma patients/life-threatening con- 
ditions, malignant disease, current fracture, renal replace- 
ment therapy/severe kidney failure (creatinine clearance 
< 30ml/min/1.73m 2 ), patients with disability, or patients dis- 
agreeing that their data will be used for scientific purposes. 
Two researchers screened all records for in-/exclusion. The 
first presentation for chest pain to the ED and all presenta- 
tions within the following three months extracted. Presen- 
tations after > 3 months due to chest pain were defined as 
a new index visit of a second episode. The extraction form 
with predefined variables was pilot-tested in 20 records. Ad- 
ditional diagnostic tests were ECG, treadmill test, coronary 
angiography, MIBI scintigraphy, echocardiography, chest X- 
ray, computer tomography (CT) of the chest or abdomen, 
sonography of the abdomen or pleura, gastroscopy, and lung 
function tests. 
We compared the number of non-invasive / invasive cardiac 
diagnostic tests in troponin positive and negative patients 
and the number of diagnostic tests after the exclusion 
of patients with STEMI diagnosis. Non-invasive / invasive 
cardiac tests included treadmill test, coronary angiography, 
MIBI scintigraphy, and echocardiography. We calculated 
average monthly tests per patient and compared mean tests 
per patient between groups. We used a t-test to quantify 
the evidence for differential number of diagnostic tests per 
patient in each period. Between-group differences were 
estimated with 95% confidence intervals. All analyses were 
performed with the statistical software R for windows [1]. 
Interpretation of this data can be found in a research article 
titled Impact of the introduction of high-sensitive troponin 
assay on the evaluation of chest pain patients in the emer- 
gency department: a retrospective study [2]). 
© 2020 The Author(s). Published by Elsevier Inc. 
This is an open access article under the CC BY-NC-ND 
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Subject Emergency Medicine 
Specific subject area We assessed whether the introduction of the hs-troponin assay resulted in 
downstream testing in patients presenting with chest pain to an emergency 
department. 
Type of data Table 
Figure 
Data 
Codes 
( continued on next page ) 
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 How data were acquired Retrospective chart review. Data extraction methods have been previously 
described [3] . The local ethics committee approved the study (KEK-ZH number 
2014-0506) in December 2014. 
All analyses were performed with the statistical software R for windows. 
Standard test period: Troponin T-Test Assay: CARDIAC T, Ref. 04491815 190, 
Cobas®, Roche) was used with a limit of detection 0.01ng/ml troponin T and a 
cut-off of ≥0.01ng/ml [4] . 
Hs-troponin test period: Troponin T hs STAT assay, Ref. 05092728190 V8, 
Cobas®, Roche (fourth generation hs-troponin T assay). Limit of detection of 
0.003ng/ml troponin. The cut-off for pathological hs-troponin values was 
defined at ≥0.014ng/ml, the 99. percentile of the reference population 
(coefficient of variation < 10% [5] ). None of the assay batches known to have 
calibration errors (batch numbers 157120, 160197, and 163704, produced 
between October 2009 and April 2012, with the latest expiration date of 
October 2012) were used. 
Data format Raw source data 
Analyzed 
Filtered 
Parameters for data collection Primary diagnosis 
Troponin test result: positive / negative 
Number of additional tests: ECG, treadmill test, coronary angiography, MIBI 
scintigraphy, echocardiography, chest X-ray, computer tomography (CT) of the 
chest or abdomen, sonography of the abdomen or pleura, gastroscopy, lung 
function tests 
Description of data collection Retrospective chart review. Two researchers screened all records. The first 
presentation for chest pain to the ED and all presentations within three 
months were considered and extracted. Presentations after > 3 months due to 
chest pain were extracted as a new index visit of a second episode. 
Data were extracted into a predefined extraction form. One researcher not 
involved in the extraction process assessed the data extraction quality. The 
final diagnosis was based on the diagnosis of the discharge letter or, in 
patients with follow-up visits / readmissions, adjudicated by a committee not 
involved in the data extraction and blinded to the discharge diagnosis of the 
first letter. 
Data source location Institution: Kantonsspital Winterthur 
City/Town/Region: Winterthur 
Country: Switzerland 
Data accessibility The data is hosted on a public repository. 
Repository name: Mendeley.com 
Data identification number: 10.17632 
Direct URL to data: http://dx.doi.org/10.17632/nktjd25y6k.1 
Related research article Jakob M. Burgstaller, Ulrike Held, Isaac Gravestock, Benjamin S. Klauser, Laura 
M. Gort, Lina Melzer, Susann Hasler, Tenzin D. Bierreth, Sarah E. Müller, Johann 
Steurer, Maria M. Wertli, Impact of the introduction of high-sensitive troponin 
assay on the evaluation of chest pain patients in the emergency department: a 
retrospective study, Am J Med, in press [2] . 
Value of the data 
• This data article represents data and additional analyses based on methods used in the orig-
inal article and provides detailed insight in how the introduction of the hs-troponin assay
influenced the diagnostic assessment in patients presenting with chest pain to the ED. 
• The data will benefit clinicians and researchers because they provide a detailed description
of a real-life setting. 
• The dataset includes data for all patients. This data will allow other researchers to compare
their own data and to perform patient independent meta-analyses. 
• The data may benefit other researchers and clinicians to develop effective algorithms on how
to test patients presenting with chest pain to the ED. 
Effective algorithm to assess and identify patient at risk for acute coronary syndrome without
overtesting may benefit the healthcare system in the long term. 
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Table 1 
Average diagnostic test before and after the introduction of the hs-troponin test. 
Troponin I test Hs-Troponin Comparison Troponin I 
vs. Hs-Troponin period 
Mean (SD) Mean (SD) Beta (95% CI) p-value 
non-invasive / invasive cardiac 
diagnostic tests ‡ in trop + patients 
1.2 (0.7) 1.0 (0.7) 0.20 (0.04 - 0.35) 0.012 
non-invasive / invasive cardiac 
diagnostic tests ‡ in trop- patients 
0.3 (0.6) 0.2 (0.5) 0.16 (0.09 - 0.23) < 0.001 
Diagnostic tests§ in trop + patients 
without STEMI patients 
3.2 (0.9) 2.9 (1.0) 0.35 (0.09 - 0.60) 0.008 
Diagnostic tests§ in trop- patients 
without STEMI patients 
2.2 (1.1) 1.7 (0.8) 0.44 (0.32 - 0.56) < 0.001 
SD, standard deviation; CI, confidence interval. 
‡ Non-invasive / invasive cardiac tests: treadmill test, coronary angiography, Mibi-scintigraphy, and echocardiography. 
§Average number of additional test: ECG, coronary angiography, Mibi-scintigraphy, echocardiography, treadmill test, chest 
X-ray, computer tomography (CT) of the chest or abdomen, sonography of the abdomen or pleura, gastroscopy, lung 
function tests. 
1
 
t  
s  
S  
s  
m  
t  
b  
F  
n
 
e  
s
2
2
 
p  
(  
r  
u  
e
 
s  
D  
i
2
 
s  
f. Data description 
The dataset in this article describes the number of diagnostic test before and after the in-
roduction of the hs-troponin test. In Table 1 the average monthly tests for two analyses are
ummarized: non-invasive / invasive cardiac tests, overall diagnostic tests after the exclusion of
TEMI patients. Fig. 1 a describes the average overall monthly number of non-invasive and inva-
ive cardiac tests per patients in the full patient sample ( n = 1274). Fig. 1 b describes the average
onthly number of non-invasive and invasive cardiac tests per patients with positive and nega-
ive troponin test for all patients ( n = 1274). Fig. 2 a describes the average overall monthly num-
er of diagnostic tests per patients after exclusion of patients with STEMI diagnosis ( n = 1173).
ig. 2 b describes the average monthly number of diagnostic tests per patients with positive and
egative troponin test after exclusion of patients with STEMI diagnosis ( n = 1173). 
In the repository, a dataset describes the raw data required to replicate the analysis on av-
rage monthly number of tests. The code file describes the codes used for the analysis for the
tatistical software R. 
. Experimental design, materials, and methods 
.1. Design and data 
Data includes records from a single-center, retrospective medical chart review of patients
resenting to one of the ten largest hospitals in Switzerland, the cantonal hospital Winterthur
 > 30 ′ 0 0 0 ED visits annually), between December 1, 2009 and December 31, 2011. This time pe-
iod was chosen because on December 1, 2010 a hs-troponin assay was implemented and in Jan-
ary 2012 an outpatient clinic near the hospital opened and many eligible patients were treated
lsewhere. 
Data includes 1,274 patient records of ED visits with at least one troponin test (597 in the
tandard troponin T and 677 in the hs-troponin test period) between December 1, 2009 and
ecember 31, 2011. The data includes 1274 patient records with at least one troponin test (597
n the standard troponin T and 677 in the hs-troponin test period). 
.2. Material 
Data extraction methods have been previously described [3] . Two researchers (TD, SM)
creened all 30 0 0 records with the ICD-10 codes (R07.1-4 ( n = 2438) and I20-24 ( n = 562)
or inclusion. Overall, 1,467 records (6.6%) met the inclusion criteria and were extracted. 
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Fig. 1. a) (top figure): Average overall monthly number of non-invasive and invasive cardiac tests per patients in the full 
patient sample (n = 1,274); b) (figure below): Average monthly number of non-invasive and invasive cardiac tests per 
patients with positive and negative troponin test for all patients (n = 1,274) 
 
 
 
 Data were extracted into a predefined extraction form. Data extraction quality of six prede-
fined parameters (troponin test result, pain reproducible by movement, coronary angiography,
recommendation for further diagnostic evaluation, recommendation for further treatment, and
the discharge diagnosis) in 379 (26%) ED visits showed an overall error rate was 5.4%, 95% con-
fidence interval (CI) 4.5–6.4); the error rate for the troponin values was 0.8%, 95%-CI 0.2–2.5). 
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Fig. 2. a) (top figure): Average overall monthly number of diagnostic tests per patients after exclusion of patients with 
STEMI diagnosis (n = 1,173). b) (figure below): Average monthly number of diagnostic tests per patients with positive 
and negative troponin test after exclusion of patients with STEMI diagnosis (n = 1,173). 
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(  The final diagnosis used for the primary outcome was based on the diagnosis of the dis-
harge letter or, in patients with follow-up visits / readmissions, adjudicated by a committee
ot involved in the data extraction (JS, UH, JB, MW) and blinded to the discharge diagnosis
f the first letter. First, one of us (BK) reviewed all records of follow-up visits to the hospital
ED visits, outpatient treatment, and hospitalizations) within three months after the initial
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 ED consultation for changes in the discharge diagnosis. Out of 263 episodes with additional
visits, 163 (62%) were related and 100 (38%) were not related to the index visit. Second,
the independent committee reviewed all available medical records (clinical findings, imaging
studies, non-invasive and invasive diagnostics, laboratory tests and discharge letters) of the
follow-up evaluation or hospitalization of all 163 potentially related visits and adjudicated
the final diagnosis. In 148 visits (90.7%) the primary diagnosis was confirmed. Changes in the
final discharge diagnosis were adjudicated from unclear chest pain in 15 visits (5.8%) to acute
coronary syndrome in 3 patients (1.1%: NSTEMI n = 1, unstable angina n = 2), stable angina
without acute coronary syndrome in 5 patients (1.9%), cholecystitis / choledocholithiasis in 3
patients (1.1%). The diagnosis was changed in one patient to an upside-down stomach (0.3%),
polyserositis (0.3%), or disseminated tuberculosis (0.3%), respectively. 
2.3. Methods 
We compared the number of non-invasive / invasive cardiac tests (i.e. treadmill test, coronary
angiography, MIBI scintigraphy, and echocardiography) and the number of diagnostic tests after
the exclusion of STEMI patients. We calculated average monthly tests per patient and compared
mean tests per patient between groups. We used a t-test to quantify the evidence for differential
number of tests per patient record in each period. Between-group differences were estimated
with 95% confidence intervals. All analyses were performed with the statistical software R for
windows [1] . 
To access the data and the full codes please go to http://dx.doi.org/10.17632/nktjd25y6k.1 . 
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